Fructose aggravates copper-deficiency-induced cardiac remodeling by inhibiting SERCA2a

Yi Xu,Qiuxia Xu,Zhirui Zheng,Xin Jiang,Yuansen Shi,Yipu Huang,Yun Liu
DOI: https://doi.org/10.1093/jpp/rgae002
2024-01-25
Journal of Pharmacy and Pharmacology
Abstract:Abstract Objectives Accumulating evidence demonstrates that copper deficiency (CuD) is a risk factor for cardiovascular diseases, besides, fructose has been strongly linked to the development of cardiovascular diseases. However, how CuD or fructose causes cardiovascular diseases is not clearly delineated. The present study aims to investigate the mechanism of CuD or fructose on cardiac remodeling. Methods We established a model of CuD- or fructose-induced cardiac hypertrophy in 3-week-old male Sprague–Dawley (SD) rats by CuD diet supplemented with or without 30% fructose for 4 weeks. In vitro study was performed by treating cardiomyocytes with tetrathiomolydbate (TM) and fructose. Echocardiography, histology analysis, immunofluorescence, western blotting, and qPCR were performed. Key findings Our findings revealed that CuD caused noticeable cardiac hypertrophy either in the presence or absence of fructose supplement. Fructose exacerbated CuD-induced cardiac remodeling and intramyocardial lipid accumulation. Furthermore, we presented that the inhibition of autophagic flux caused by Ca2+ disturbance is the key mechanism by which CuD- or fructose-induced cardiac remodeling. The reduced expression of sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2a (SERCA2a) in cardiomyocytes accounts for the elevated cytoplasmic Ca2+ concentration. Conclusions Collectively, our study suggested that fructose aggravated CuD-induced cardiac remodeling through the blockade of autophagic flux via SERCA2a decreasing-induced Ca2+ imbalance.
pharmacology & pharmacy
What problem does this paper attempt to address?